OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study

OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study

ABSTRACT Objective To compare the frequency of respiratory tract infections in children treated with OM-85 BV and placebo during the 3-month therapy period, and observation for a further 3 months after treatment. Methods A randomized, double-blind, placebo-controlled trial was conducted with 54 ch...

Full description

Bibliographic Details
Main Authors: Fátima Cleonice de Souza, Magáli Mocellin, Renata Ongaratto, Lidiane Alves de Azeredo Leitão, Frederico Orlando Friedrich, Victória d’A Silveira, Marcelo Comerlato Scotta, Paulo Márcio Pitrez, Leonardo Araújo Pinto
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2020-02-01
Series:Einstein (São Paulo)
Subjects:
Respiratory tract infections/drug therapy
Placebo
Adjuvants, immunologic/therapeutic use
Child
Primary prevention
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100240&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100240&tlng=en

Similar Items